Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Halobetasol Propionate Spray in Plaque Psoriasis
NCT03298581Phase 2Withdrawn
- Sponsor
- Sun Pharma
- Start
- Jan 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Halobetasol propionate 0.05% lotion in plaque psoriasis, sponsored by Sun Pharma. Planned start Jan 2017; status: withdrawn.
02
Drugs
Halobetasol propionate 0.05% lotion
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03298581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03298581.